In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors.
about
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmCombination-targeting to multiple endothelial cell adhesion molecules modulates binding, endocytosis, and in vivo biodistribution of drug nanocarriers and their therapeutic cargoes.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Biological functionalization of drug delivery carriers to bypass size restrictions of receptor-mediated endocytosis independently from receptor targeting.Enhancing biodistribution of therapeutic enzymes in vivo by modulating surface coating and concentration of ICAM-1-targeted nanocarriers.Orally active-targeted drug delivery systems for proteins and peptides.Targeted endothelial nanomedicine for common acute pathological conditions.Biofabricated nanoparticle coating for liver-cell targeting.Tumor targeting HPMA-porphyrin-99mTc copolymer molecular imaging agent.Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier.Mono and dually decorated nanoliposomes for brain targeting, in vitro and in vivo studies.The targeting nanothin polyelectrolyte shells in system with immobilized bacterial cells for antitumor factor production.How Carrier Size and Valency Modulate Receptor-Mediated Signaling: Understanding the Link between Binding and Endocytosis of ICAM-1-Targeted Carriers.Precision engineering of targeted nanocarriers.Enhanced Delivery and Effects of Acid Sphingomyelinase by ICAM-1-Targeted Nanocarriers in Type B Niemann-Pick Disease Mice.Nanovesicle delivery to the liver via retinol binding protein and platelet-derived growth factor receptors: how targeting ligands affect biodistribution.Targeted delivery of pharmacological chaperones for Gaucher disease to macrophages by a mannosylated cyclodextrin carrier.
P2860
Q27026630-75BFD505-C3BA-4682-A6C8-B19BAE4584EEQ34119423-A4FF40BD-4976-4876-B629-FAA3B24483B5Q34447986-B627CAE4-46F8-40B7-9B4F-1268771BC388Q37514889-2C09B3B5-08B3-4D8A-8F34-D7CC3C6DE684Q37724781-550A773B-C34A-43F5-AA86-5B3FA5B57C75Q38223053-59AF8FF6-2D49-403C-A07D-1A87F3455359Q38598987-D98809E7-A42C-43B1-8560-EC19BEF61EBAQ38857226-B5619F8A-930A-47B3-B175-2AA568C33152Q38947849-71B5B6FC-D8DC-4C3C-A989-B49D14E99E6AQ39021929-159627EC-551C-4F2D-B65F-8B3F90172343Q39043216-F55601DB-12A1-4B0F-94E3-D8A52DC834A1Q43975509-C8AE6754-BF8B-4A2A-AB85-51266250FF27Q47276739-87815AD0-C6F3-4DB6-9F62-2EE644C53832Q50049633-2C579995-09DC-4E2F-9C17-A104C50FC741Q50948507-8F805BDC-0C90-4FF8-93A9-41125BBE7D37Q51197424-01AC2111-18C2-4639-86AF-522F674EE697Q51750678-37568B08-5FBF-448B-A128-033D5D2311D8
P2860
In vivo performance of polymer nanocarriers dually-targeted to epitopes of the same or different receptors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
In vivo performance of polymer ...... e same or different receptors.
@en
In vivo performance of polymer ...... e same or different receptors.
@nl
type
label
In vivo performance of polymer ...... e same or different receptors.
@en
In vivo performance of polymer ...... e same or different receptors.
@nl
prefLabel
In vivo performance of polymer ...... e same or different receptors.
@en
In vivo performance of polymer ...... e same or different receptors.
@nl
P2093
P2860
P1433
P1476
In vivo performance of polymer ...... e same or different receptors.
@en
P2093
Edward H Schuchman
Iason T Papademetriou
Silvia Muro
P2860
P304
P356
10.1016/J.BIOMATERIALS.2013.01.069
P577
2013-02-09T00:00:00Z